Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model. - Wikidata - awgldk - TriplyDB

Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model.

Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model.

http://www.wikidata.org/entity/Q39587262

about

T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-Antitrypsin Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats Expanding the clinical indications for α(1)-antitrypsin therapy Alpha 1-antitrypsin therapy mitigated ischemic stroke damage in rats.α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus.Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury.Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis.Human plasma protein N-glycosylation Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.Serpins, immunity and autoimmunity: old molecules, new functions.Immune-modulating effects of alpha-1 antitrypsin.Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update.Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions Curcumin protects against collagen-induced arthritis via suppression of BAFF production.α-Linoleic acid enhances the capacity of α-1 antitrypsin to inhibit lipopolysaccharide-induced IL-1β in human blood neutrophils Brief Report: Genetic Variation of the α1 -Antitrypsin Gene Is Associated With Increased Autoantibody Production in Rheumatoid Arthritis.Activation of proteinase 3 contributes to Non-alcoholic Fatty Liver Disease (NAFLD) and insulin resistance.The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity.iTRAQ-Based Proteomics of Chronic Renal Failure Rats after FuShengong Decoction Treatment Reveals Haptoglobin and Alpha-1-Antitrypsin as Potential Biomarkers.Anti-inflammaging effects of human alpha-1 antitrypsin.Low Levels of IgG Recognizing the α-1-Antitrypsin Peptide and Its Association with Taiwanese Women with Primary Sjögren's Syndrome.Identification of Novel Chondroprotective Mediators in Resolving Inflammatory Exudates.Novel therapeutic uses of alpha-1 antitrypsin: a window to the future.Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment.IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies.Point Mutation of a Non-Elastase-Binding Site in Human α1-Antitrypsin Alters Its Anti-Inflammatory Properties.SERPINB3 Delays Glomerulonephritis and Attenuates the Lupus-Like Disease in Lupus Murine Models by Inducing a More Tolerogenic Immune Phenotype

P2860

Q26829272-5DF19363-6FD9-4633-8894-74E07F36400E Q26858837-CC8E7ABA-D78E-4B1D-B045-D4E2FF2AEAA3 Q27000764-ADFD21DA-53D9-488D-A3F3-F1D7FA136871 Q33671373-1AB310E1-BDF5-4993-A7D1-27E7D970781A Q35286904-0F2AAA9E-EA45-457C-A186-DE4D88C7B469 Q36032325-C3A27C43-539B-49FB-AE2B-1ABA20620075 Q36290085-675C7EE9-9678-42EA-B845-C02F3725B1B7 Q36346287-A418511A-3550-4A8F-9BB2-2873EDFF14AA Q36963945-72DAB908-EC91-4F4F-B3BB-F50CB76DF89F Q37943809-A313F758-D3F0-4740-B72B-F8562D31B5E5 Q37986292-3FAB257E-F013-40B4-BB4D-97CC434237FF Q38074594-84DA2221-274B-4E7C-BDC7-5D901A86D565 Q38214040-3AA2FCE8-BC42-446D-8BC2-F89DB5B449A2 Q38643507-84D03874-42F8-4EE3-BEAB-DE9449C6CC18 Q38711081-45D8BD7C-79F2-47BE-BD6D-F25B25791BE4 Q39238093-B76BCFA2-15B8-4B02-B4DE-207CB36D3C7B Q39565971-42D3E6B2-DCCE-409D-ACCD-266BA716BE33 Q40242438-144D5750-DA3E-464D-AAFF-45E434256B3C Q40974696-426F42E0-5CAE-4E68-B1E5-C43C85AFDA7D Q42234561-DFCD8019-8A4E-4578-B1C9-C37E087E1E4C Q42278003-F90F1072-E6B0-465B-AB24-D266C241D248 Q42778200-8F9BD741-11B9-4CD0-8907-81173466D10A Q47274670-B1597BC5-5342-429C-A400-E77503C97FA7 Q48189143-158C3B95-9F41-4B65-AB1A-98752399C1EE Q51534901-5AC2910B-73AA-4CF6-9155-282023709AF8 Q51568269-757969A8-64AF-48EA-853B-177A10C2B245 Q52582325-1DCDB045-4A55-4D22-AE0D-B7913A7C876E Q55438350-875DB8BA-2A0E-4C7A-88FB-4BD491E3D12C Q58750515-4E8415B9-5D6A-4CB9-81A9-67B7480821B0

P2860

Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model.

http://www.wikidata.org/entity/Q39587262

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Alpha-1 antitrypsin protein an ...... is development in mouse model.

@en

Alpha-1 antitrypsin protein an ...... is development in mouse model.

@nl

type

label

Alpha-1 antitrypsin protein an ...... is development in mouse model.

@en

Alpha-1 antitrypsin protein an ...... is development in mouse model.

@nl

prefLabel

Alpha-1 antitrypsin protein an ...... is development in mouse model.

@en

Alpha-1 antitrypsin protein an ...... is development in mouse model.

@nl

P1433

Q39587262-F5AFD8AB-B09D-4957-8A6C-A6F386A5BF61

P1476

Q39587262-2EAB6114-8AFB-43E0-8A51-EE51096E0441

P2093

Q39587262-1DBED746-0767-40AD-8E29-6663CE668133

Q39587262-459C5820-487B-4349-947D-FCDEBB25F9B2

Q39587262-72AF1FAC-2C80-4F2F-AEF3-B65982F010BC

Q39587262-AFDFB877-BC58-4FEC-BA0C-C2198713C5C1

Q39587262-BB25D8C3-74EF-4BA4-9BA6-E1772BBAB032

Q39587262-C66D7F64-59F2-475D-8F23-43CC6C9C7D34

P2860

Q39587262-058A36C7-7869-4662-821D-D8A8494D872C

Q39587262-0A01B808-F4FC-4DE2-92BE-31B708485344

Q39587262-11CC4106-5A98-4426-993F-263B28FB1963

Q39587262-1F913C0F-50F8-4A33-8720-5D6393607E0A

Q39587262-28D54D1B-7D0D-4CCA-938B-653DF08083FE

Q39587262-29ECBB91-7588-4218-B2A7-6F60878DE7A9

Q39587262-33E18230-0642-482C-97E8-1884D497AE80

Q39587262-344FE0C3-CEDE-4771-8F4C-7A7F1943ECB0

Q39587262-3DB05D3B-6C04-4F0A-A297-D6CC3A799C3C

Q39587262-3F9992ED-FA87-45B8-9BB5-AD1178BEC266

P2888

Q39587262-19E2D9A6-4B0C-4ACB-9E43-D699E1580CD3

P304

Q39587262-D8BA1465-E84D-4EF7-9AD5-F7C988D6561A

P31

Q39587262-C3D9B80A-CDE2-4E70-B3BA-4C08EA35690F

P356

Q39587262-12B215EA-5F86-4349-970D-DBD5A7F3F8B5

P478

Q39587262-BDE5F5B8-2E7C-43F8-98D4-1735A1B723BF

P50

Q39587262-03DF852D-82DA-4ADD-A364-9D711F94D0DB

Q39587262-342C4024-ABC6-41D6-AC89-53D297BE9E02

P577

Q39587262-C89C68E1-1C94-43B4-9FFE-D291929D0D21

P5875

Q39587262-26B7CD75-E4A3-491E-9F55-2971ADFC5284

P6179

Q39587262-EF1C56FA-7158-49CB-BC13-D9BBC5571D2F

P698

Q39587262-7839B9DD-FBB0-4EC0-B631-CE653E56095C

P932

Q39587262-00F2F88C-5D34-4FCC-B0DF-BDD6200E5595

P356

P1433

Journal of Translational Medicine

P1476

Alpha-1 antitrypsin protein an ...... is development in mouse model.

@en

P2093

Christian Grimstein

http://www.w3.org/2001/XMLSchema#string

Mark A Atkinson

http://www.w3.org/2001/XMLSchema#string

Mark L Brantly

http://www.w3.org/2001/XMLSchema#string

Minoru Satoh

http://www.w3.org/2001/XMLSchema#string

Sihong Song

http://www.w3.org/2001/XMLSchema#string

Young-Kook Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

Cytokines in the pathogenesis of rheumatoid arthritis

Evolving concepts of rheumatoid arthritis

Adeno-associated virus serotypes: vector toolkit for human gene therapy.

Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.

Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis.

New drugs for rheumatoid arthritis.

Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus.

P2888

P304

21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-9-21

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Martha Campbell-Thompson

Clive Wasserfall

P577

2011-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49942640

http://www.w3.org/2001/XMLSchema#string

P6179

1004184058

http://www.w3.org/2001/XMLSchema#string

P698

21345239

http://www.w3.org/2001/XMLSchema#string

P932

3050720

http://www.w3.org/2001/XMLSchema#string